Cancer Biological Therapy Market size in Brazil to grow at over 7.4% CAGR by 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

Cancer Biological Therapy Market size in Brazil to grow at over 7.4% CAGR by 2023

Description:

Get more details @ Companies are focusing on innovative products with minimum adverse effects, as well as targeting emerging applications to leverage growth opportunities. They are concentrating their efforts on R&D in order to invent novel drugs. – PowerPoint PPT presentation

Number of Views:30

less

Transcript and Presenter's Notes

Title: Cancer Biological Therapy Market size in Brazil to grow at over 7.4% CAGR by 2023


1
Global Cancer Biological Therapy Industry to
reach USD 100 billion by 2023 Fractovia.org
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights of Cancer Biological Therapy
Market
  • Global Cancer Biological Therapy Market size
    contribution was 61.4 billion for 2015 with
    overall revenue predicted to surpass 101 billion
    during forecast period with CAGR of more than
    6.1.
  • Increase in proportion of different kinds of
    cancers and rising acceptance of biological
    treatment is predicted to drive global cancer
    biological therapy industry trends.
  • As per WHO reports, proportion of new cases of
    cancer are expected to increase by 70.1 in
    future and the reason for this being enhanced
    consumption of alcohol and tobacco. Increase in
    aging population all across the globe is
    projected to fuel global biological cancer
    therapy industry due to correlation between aging
    and new cases.
  • High treatment cost of cancer therapy is mainly
    owing to high price of medicines. Lot of
    expenditure is incurred on recognizing and
    designing a medicine, acquiring preclinical
    information and clinical trials.
  • It is also forecast that each medicine costs more
    than 1.2 billion. Drug monopoly is yet another
    factor adding to high medicine price.

3
Continued
  • Global cancer biological therapy industry was
    segmented into products like cytokines,
    monoclonal antibodies, blood cell growth factors,
    monoclonal antibodies and vaccines. Monoclonal
    antibodies segment contributed more than 21.1
    billion for 2015.
  • Antibody treatment is the most significant and
    successful approach used for treating solid burns
    as well as hematological malignance. This is one
    of the reason for the segment growth.
  • This segment is sub -segmented into bi-specific
    monoclonal antibodies, naked monoclonal
    antibodies and conjugated monoclonal antibodies.
    Bi-specific monoclonal antibodies sub-segment is
    predicted to register CAGR of 6.51 during
    forecast timeline.
  • Vaccines segment is projected to record CAGR of
    about 17.3 during forecast timeline. Preventive
    vaccines for HPV (Human papillomavirus) and HBV
    (Hepatitis B Virus) can encourage antibody
    production that binds to microbes and block their
    ability to proliferate cause infection.

4
U.S. Cancer Biological Therapy Market size, by
product, 2012 - 2023 (USD Million)

5

Browse Full Market Research Report Cancer
Biological Therapy Market _at_ http//bit.ly/2jTmBgO
Request for a Sample of this Research report
_at_ https//www.fractovia.org/request-sample/161
6
Stay In Touch Website https//www.fractovia.org
Social Media
Write a Comment
User Comments (0)
About PowerShow.com